BWP
COCH icon

BlueStem Wealth Partners’s Envoy Medical COCH Stock Holding History

BlueStem Wealth Partners’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.95K Hold
10,454
– – ﹤0.01% 124
2025
Q4 		$6.91K Hold
10,454
– – ﹤0.01% 125
2025
Q3 		$8.11K Hold
10,454
– – ﹤0.01% 124
2025
Q2 		$14.8K Hold
10,454
– – ﹤0.01% 119
2025
Q1 		$13.6K Hold
10,454
– – ﹤0.01% 103
2024
Q4 		$14.9K Buy
+10,454
New +$23.7K ﹤0.01% 101

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM

BlueStem Wealth Partners's COCH Position: Q1 2026 in Review

BlueStem Wealth Partners held its Envoy Medical (COCH) position steady in Q1 2026 at 10,454 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #124.

BlueStem Wealth Partners first reported a position in COCH in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.9K in Q4 2024. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • BlueStem Wealth Partners held 10,454 shares of Envoy Medical worth $6.95K as of Q1 2026.
  • BlueStem Wealth Partners left its Envoy Medical share count unchanged in Q1 2026.
  • Envoy Medical made up ﹤0.01% of BlueStem Wealth Partners's portfolio in Q1 2026, its #124 holding.
  • BlueStem Wealth Partners first reported a position in Envoy Medical in Q4 2024 and has held it in 6 quarters since.
  • BlueStem Wealth Partners's Envoy Medical position peaked at $14.9K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on BlueStem Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.